Kevin Bicker designs peptidomimetics and small molecules via SAR, combinatorial libraries and structure‑based screening. Focus areas include antifungal and anti‑biofilm agents and modulators of cancer resistance, emphasizing potency, selectivity and translational in vitro validation.